Search - Archive ouverte HAL Access content directly

Filter your results

11 Results
authFullName_s : C. Recher

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03623367v1

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia

M-A Hospital , A. Jacquel , F Mazed , E Saland , C. Larrue et al.
Leukemia, 2018, 32 (3), pp.597-605. ⟨10.1038/leu.2017.284⟩
Journal articles hal-02365710v1

Rapamycin inhibits growth and survival of D-816-V-mutated c-kit mast cells

M. Gabillot-Carré , Y. Lepelletier , M. Humbert , P. de Sepuvelda , N. Ben Hamouda et al.
Blood, 2006, 108, pp.1065-1072
Journal articles hal-00022484v1

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.

S. Park , N. Chapuis , Franck Saint-Marcoux , C. Recher , T. Prebet et al.
Leukemia, 2013, 27 (7), pp.1479-86. ⟨10.1038/leu.2013.17⟩
Journal articles hal-00849677v1
Image document

The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs

G. Bossis , J. E. Sarry , C. Kifagi , M. Ristic , E. Saland et al.
Cell Reports, 2014, 7 (6), pp.1815--23. ⟨10.1016/j.celrep.2014.05.016⟩
Journal articles hal-02191559v1

Autologus stern celle transplantation (ASCT) versus oral melphalan and high-dose dexamethasone in patients with AL (primary) amyloisdosis : results of the French multicentric randomized trial (MAG and IFM intergroup).

Arnaud Jaccard , P. Moreau , V. Leblond , X. Leleu , L Bennoubker et al.
Communication orale présentée à 'The American Society of Hematology 47th Annual meeting and Exposition", Dec 2005, Nouvelle Orléans (Louisiane), United States
Conference papers hal-01135622v1
Image document

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03376715v1
Image document

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Mathilde Hunault-Berger , N. Maillard , C. Himberlin , C. Recher , Aline Schmidt-Tanguy et al.
Blood Cancer Journal, 2017, 7 (6), pp.e568. ⟨10.1038/bcj.2017.50⟩
Journal articles inserm-01814864v1

Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis

C. Bulai Livideanu , Pol‐andré Apoil , B. Lepage , M. Eischen , C. Laurent et al.
Clinical and Experimental Allergy, 2016, 46 (1), pp.133-141. ⟨10.1111/cea.12627⟩
Journal articles istex hal-03444089v1

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

C. Berthon , E. Raffoux , X. Thomas , N. Vey , C. Gomez-Roca et al.
Lancet Haematology, 2016, 3 (4), pp.e186-e195. ⟨10.1016/S2352-3026(15)00247-1⟩
Journal articles hal-01791279v1

Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells

S. Scotland , E. Saland , N. Skuli , Fabienne de Toni , H. Boutzen et al.
Leukemia, 2013, 27 (11), pp.2129-2138. ⟨10.1038/leu.2013.107⟩
Journal articles hal-02650325v1